Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HLCS | P50747 | 6/20 | 0.76 |
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.63 |
| ▸ | MEN1 | O00255 | 1/20 | 0.63 |
| ▸ | ABL1 | P00519 | 1/20 | 0.63 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | PKM | P14618 | 1/20 | 0.63 |
| ▸ | IDE | P14735 | 1/20 | 0.63 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.63 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.63 |
| ▸ | CA12 | O43570 | 7/20 | 0.46 |
| ▸ | CA1 | P00915 | 7/20 | 0.46 |
| ▸ | CA2 | P00918 | 7/20 | 0.46 |
| ▸ | CA9 | Q16790 | 7/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5599921 | 1.00 | HLCS (0.76) | HLCSTDP1MEN1ABL1LMNA | |
| SCHEMBL771649 | 1.00 | HLCS (0.76) | HLCSTDP1MEN1ABL1LMNA | |
| SCHEMBL5491731 | 0.90 | TDP1 (0.67) | HLCSTDP1MEN1ABL1LMNA | |
| SCHEMBL14822342 | 0.87 | HLCS (1.00) | HLCSTDP1MEN1ABL1LMNA | |
| SCHEMBL16141183 | 0.85 | HLCS (1.00) | HLCSTDP1MEN1ABL1LMNA | |
| SCHEMBL14822482 | 0.85 | HLCS (1.00) | HLCSTDP1MEN1ABL1LMNA | |
| SCHEMBL16141171 | 0.85 | HLCS (0.75) | HLCSTDP1MEN1ABL1LMNA | |
| SCHEMBL16664701 | 0.84 | HLCS (0.72) | HLCSTDP1MEN1ABL1LMNA | |
| SCHEMBL19278027 | 0.84 | HLCS (0.72) | HLCSTDP1MEN1ABL1LMNA | |
| SCHEMBL15142513 | 0.84 | TDP1 (0.68) | HLCSTDP1MEN1ABL1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 11590 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024151843-A1 | TARGETED UNIVERSAL DELIVERY SYSTEM OF DON AND OTHER DRUGS | THE JOHNS HOPKINS UNIVERSITY (US) | 2024-07-18 | — | — | WO | claimed |
| US-20240218424-A1 | METHODS FOR TETHERING RIBONUCLEIC ACIDS IN BIOLOGICAL SAMPLES | 10X GENOMICS, INC. | 2024-07-04 | — | — | US | claimed |
| EP-4392012-A1 | COSMETIC COMPOSITIONS | The Boots Company PLC (GB) | 2024-07-03 | — | — | EP | claimed |
| WO-2024137860-A1 | METHODS FOR TETHERING RIBONUCLEIC ACIDS IN BIOLOGICAL SAMPLES | 10X GENOMICS, INC. (US) | 2024-06-27 | — | — | WO | claimed |
| US-20240197633-A1 | PEGYLATED LIPID, LIPOSOME MODIFIED BY THE LIPID, PHARMACEUTICAL COMPOSITION CONTAINING THE LIPOSOME, FORMULATION AND APPLICATION THEREOF | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2024-06-20 | — | — | US | claimed |
| WO-2024129830-A1 | COMPOSITIONS AND METHODS FOR CHEMOPROTEOMICS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-06-20 | — | — | WO | claimed |
| US-20240180951-A1 | PEGYLATED LIPID, LIPOSOME MODIFIED BY THE LIPID, PHARMACEUTICAL COMPOSITION CONTAINING THE LIPOSOME, FORMULATION AND APPLICATION THEREOF | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2024-06-06 | — | — | US | claimed |
| WO-2024095026-A1 | IN VIVO TARGETING OF THERAPEUTIC MOLECULES TO THE RETINA VIA THE OPTICAL SYSTEM OF THE EYE | SEMMELWEIS EGYETEM (HU) | 2024-05-10 | — | — | WO | claimed |
| EP-4362988-A1 | ANTIMICROBIAL PEPTIDES AND THEIR USE | The University of Manchester (GB) | 2024-05-08 | — | — | EP | claimed |
| EP-4321504-A1 | PEGYLATED LIPID AND LIPOSOME MODIFIED THEREBY, AND PHARMACEUTICAL COMPOSITION COMPRISING LIPOSOME AND PREPARATION AND USE THEREOF | Xiamen Sinopeg Biotech Co., Ltd. (CN) | 2024-02-14 | — | — | EP | claimed |
| EP-0266399-A4 | REPLICATIVE RNA REPORTER SYSTEMS. | SALK INST FOR BIOLOGICAL STUDI (US) | 1989-10-12 | — | — | EP | claimed |
| EP-0289219-A2 | Method of measuring biotin | FUJIREBIO KABUSHIKI KAISHA also trading as FUJIREBIO INC. (JP) | 1988-11-02 | — | — | EP | claimed |
| WO-1988004289-A1 | NON-RADIOACTIVE NUCLEIC ACID PROBES | NATIONAL DISTILLERS AND CHEMICAL CORPORATION (US) | 1988-06-16 | — | — | WO | claimed |
| EP-0266399-A1 | REPLICATIVE RNA REPORTER SYSTEMS. | SALK INST FOR BIOLOGICAL STUDI (US) | 1988-05-11 | — | — | EP | claimed |
| WO-1987006270-A1 | REPLICATIVE RNA REPORTER SYSTEMS | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 1987-10-22 | — | — | WO | claimed |
| US-4649105-A | IMMUNOLOGY, ANTIBODY AND ENZYMES, INHIBITORS | FUJIREBIO KABUSHIKI KAISHA (JP) | 1987-03-10 | — | — | US | claimed |
| EP-0209996-A2 | Nucleic acid probes comprising N4 -(substituted amino)cytidines | SISKA DIAGNOSTICS,INC. (US) | 1987-01-28 | — | — | EP | claimed |
| EP-0152305-A2 | Method of measuring biological ligand by utilising amylase | FUJIREBIO KABUSHIKI KAISHA also trading as FUJIREBIO INC. (JP) | 1985-08-21 | — | — | EP | claimed |
| EP-0132292-A2 | Method of measuring biological ligands | FUJIREBIO KABUSHIKI KAISHA also trading as FUJIREBIO INC. (JP) | 1985-01-30 | — | — | EP | claimed |
| EP-0124366-A2 | Method of measuring biological ligands | FUJIREBIO KABUSHIKI KAISHA also trading as FUJIREBIO INC. (JP) | 1984-11-07 | — | — | EP | claimed |